Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)
Hoffmann-La Roche
Stephen V Liu; Martin Reck; Aaron S Mansfield; Tony Mok; Arnaud Scherpereel; Niels Reinmuth; Marina Chiara Garassino; Javier De Castro Carpeno; Raffaele Califano; Makoto Nishio; Francisco Orlandi; Jorge Alatorre-Alexander; Ticiana Leal; Ying Cheng; Jong-Seok Lee; Sivuonthanh Lam; Mark McCleland; Yu Deng; See Phan; Leora Horn